Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
about
Emerging opportunities for serotypes of botulinum neurotoxinsGlycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype FUnique Ganglioside Recognition Strategies for Clostridial NeurotoxinsSequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtypeThe case of botulinum toxin in milk: experimental dataOnset dynamics of type A botulinum neurotoxin-induced paralysis.Expression of the Clostridium botulinum A2 neurotoxin gene cluster proteins and characterization of the A2 complex.Toosendanin: synthesis of the AB-ring and investigations of its anti-botulinum properties (Part II).Identification of a Natural Product Antagonist against the Botulinum Neurotoxin Light Chain ProteaseUniversal and specific quantitative detection of botulinum neurotoxin genesSynthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease.Characterization of Clostridium botulinum strains associated with an infant botulism case in the United Kingdom.Characterization of botulinum progenitor toxins by mass spectrometry.A platform stratifying a sequestering agent and a pharmacological antagonist as a means to negate botulinum neurotoxicitySensitive detection of botulinum neurotoxin types C and D with an immunoaffinity chromatographic column testPEG precipitation coupled with chromatography is a new and sufficient method for the purification of botulinum neurotoxin type B [corrected].Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.Clostridium botulinum: a bug with beauty and weapon.Symptomatic relief of botulinum neurotoxin/a intoxication with aminopyridines: a new twist on an old molecule.Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?Altered protozoan and bacterial communities and survival of Escherichia coli O157:H7 in monensin-treated wastewater from a dairy lagoonHolotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.Two-component signal transduction system CBO0787/CBO0786 represses transcription from botulinum neurotoxin promoters in Clostridium botulinum ATCC 3502.Hypersensitive detection and quantitation of BoNT/A by IgY antibody against substrate linear-peptideProfile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasmFormulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization.An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists.Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detectionProgress toward development of an inhalation vaccine against botulinum toxin.Systemic colonization of clover (Trifolium repens) by Clostridium botulinum strain 2301.Recombinant holotoxoid vaccine against botulism.Using translational medicine to understand clinical differences between botulinum toxin formulations.Use of botulinum toxins in cancer therapy.The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft.Botulism diagnostics: from clinical symptoms to in vitro assays.Plasma membrane localization signals in the light chain of botulinum neurotoxin.Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typingFunction-oriented synthesis applied to the anti-botulinum natural product toosendanin.Association of botulinum neurotoxins with synaptic vesicle protein complexes.Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan.
P2860
Q26859917-E9BE30F0-8EED-429B-96BB-2563B35923E4Q27655649-16A3A09E-90E7-43FA-8643-68DF8FCF2B2AQ27671814-214C872B-05D6-4557-87B3-90040325681FQ33300918-72E8648A-9A34-4493-ACE7-067E02455127Q33549116-A33C7AD3-4214-4BAA-BA0D-D88B734C77A0Q33557078-C1B12CDE-6E29-4DCE-9ED4-BA0723A8F0E5Q33559451-80E31FC7-B5FB-496D-BE75-220DC801493AQ33643294-0C2F5B9E-614D-47B6-841F-CB754A44B29CQ33722985-9D77F034-83B3-43B1-90AF-4613CF588931Q33723538-90738564-5DC8-4F67-BA66-7B9228472CB7Q33850913-A5F51ECA-F85D-4DED-ADFB-94B93D066E21Q33856145-5125A49E-469F-4088-9D76-87CF601EF71EQ33913243-2619EA65-479B-4C9E-B225-A625CA31F398Q34074908-B4478F23-EA33-4139-9F69-2B23B9045FFAQ34232837-29F16160-9365-4731-B58D-FE91C479CB90Q34326421-3102070C-DF14-4F40-AC67-81CAC686E1AAQ34405710-CBA04B4F-CDD4-4DE0-9723-82545BFE4357Q34412430-D7480B17-0451-433C-8675-98FFEB6E8A99Q34414291-591E3A8E-AF7D-450A-83CE-0E0890F2523EQ34443530-A848B3BD-C018-4173-B988-A484D4BB8251Q34563476-7E758CC8-3BFC-4667-B78A-1840CA42D7CBQ34595178-CADFEE76-AB73-42B7-B0DB-758EF7CD73F5Q34649682-16F15B72-7FAA-4399-9903-7133EFA7AD9DQ34650600-B3083D7B-9618-407E-A364-5B044A84F33FQ35050218-D17C0C27-DDB6-47E3-BE9B-6149AFE98183Q35381107-9B150819-7C9A-482B-B46E-512A908E5006Q35669634-515B4923-53EF-42CE-9E09-8B94EF0415EAQ35839545-C296C109-E12C-4A2F-A139-266929956F7CQ35843653-B0CC8EE8-524E-4B18-8B2B-B3664AF06265Q35845993-1A6C8144-62AB-40FB-A632-550F1119FB5BQ36422119-A8FA290E-A379-401B-BC0B-F2B117850D47Q36656464-D7B01949-A008-436B-BB92-85D730414AF4Q36715757-18CDF9B6-8067-41C8-AE32-6E8B85F033D1Q36737617-79BCE6FB-40F6-4A96-A918-2604C075DB21Q36844868-92F7EA48-8FC6-4727-B49C-CEDEB9A8AEA2Q36854737-3376419F-7B4C-4B03-AA9E-70F6A5C1FE27Q36925712-27B6389C-484E-48BB-82AA-AEBD301FA0E5Q37141890-0CE83520-6431-4E09-9F56-30DCA5F3DD52Q37316102-CABB8E11-096F-4EB2-9BA6-11EF01EE4F90Q37333630-D261D143-44B0-4E03-B522-74528DE08A26
P2860
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@ast
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@en
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@nl
type
label
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@ast
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@en
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@nl
prefLabel
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@ast
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@en
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@nl
P1433
P1476
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.
@en
P2093
Bradshaw M
Johnson EA
P304
P356
10.1016/S0041-0101(01)00157-X
P577
2001-11-01T00:00:00Z